CPDR Education and Training
Post-doctoral fellows with M.D. or Ph.D. degrees from the United States and other countries actively participate in the research program and receive state-of-the-art training in basic and translational aspects of cancer research by focusing on prostate cancer. The CPDR is proud of the excellent career advancement that the CPDR trainees have demonstrated. Up to this point, thirty postdoctoral fellows have participated in our program.
Education and Training Opportunities for Graduate Students (M.P.H., Ph.D.) and Medical Students (M.D.) of Uniformed Services University of the Health Sciences (USU)
The CPDR offers opportunities for long-term and short-term training of graduate and medical students at USU. Graduate students undertake original research projects focusing on molecular biology, genetics and translational research focusing on prostate cancer. Three graduate students and several medical students have participated so far in the CPDR laboratory projects. One USU-Molecular and Cell Biology Program student completed his Ph.D. thesis at CPDR. One MPH student from the LAM completed his thesis at CPDR.
CPDR POST DOCTORAL FELLOWS 1991 - PRESENT
|Jaya Gaddipati, Ph.D||(1991-1994)|
|Axel Heidenreich, MD||(1994-1995)|
|Kekule Asgari, Ph.D||(1994-1998)|
|Linda Xu, MD||(1995-1999)|
|Chun Ling Gao, MD||(1997-2002)|
|Wei Zhang, Ph.D (CPDR & AFIP)||(1998-2002)|
|Takehiko Segawa, MD, Ph.D||(1999-2002)|
|Keiichiro Nakamura, MD, Ph.D||(1997-2001)|
|Yutaka Yasunaga, MD, Ph.D||(2000-2001)|
|Sudhir Rawal, MBBS, MS||(2000-2002)|
|Yongpeng Gu, MD, Ph.D||(2000-2006)|
|Kala Prasanna, Ph.D||(2002-2006)|
|Syed Shaheduzamman, Ph.D||(2002-2004)|
|Chen Sun, MD, Ph.D||(2003-2006)|
|Aijun Liu, MD||(2003-2005)|
|Lionel Banez, MD||(2003-2005)|
|Xiaoqin Fu, Ph.D||(2003-2006)|
|Anu Vishwanath, MD||(2003-2004)|
|Bungo Furusato, Ph.D||(2003-2004)|
|Kee-Hong Kim, BTech, Ph.D||(2004-2006)|
|Katsuaki Masuda, MD, Ph.D||(2004-2007)|
|Govindan Vaidyanathan, Ph.D||(2004-2007)|
|Jun Miki, PhD||(2004-2007)|
|Hongzhen Li, PhD||(2007-2009)|
|Ahmed Mohamed, MD, Ph.D||(2006-2009)|
|Ying Hu, MD.PhD||(2006-2009)|
|Shashwat Sharad, Ph.D||(2009-Present)|
|Shiela Macalindong, MD||(2010-Present)|
|Kristen Nickens, Ph.D||(2010-Present)|
|Nicolas Griner, Ph.D||(2011-Present)|
|Anshu Rastiogi, Ph.D||(2011-Present)|
Read the FEBRUARY 2014 Newsletter
Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
Thangapazham R, Saenz F, Katta S, Mohamed AA, Tan S-H, Petrovics G, Srivastava S and Dobi A.
BMC Cancer. 2014: Jan 13;14:16.
ERG rearrangement and protein expression in the progression to castration-resistant prostate cancer.
Gsponer JR, Braun M, Scheble VJ, Zellweger T, Rentsch CA, Bachmann A, Perner S, Sesterhenn IA,
Srivastava S, Dobi A, Bubendorf L, Ruiz C.
Prostate Cancer Prostatic Dis. 2014 Jan 28. doi: 10.1038/pcan.2013.62. [Epub ahead of print]